Follicular Lymphoma

FoRT

A Phase III multi-centre randomised controlled trial of low dose radiotherapy for follicular lymphoma.

SCHRIFT

Short CHemoRadioImmunotherapy in Follicular Lymphoma Trial of 90Y Ibritumomab tiuxetan (ZevalinTM) as therapy for first and second relapse in Follicular Lymphoma - a Prospective Phase II study

Pacifico

Phase 3

Older patients

Follicular Lymphoma

Comparison of 1st line R-CVP V R-FC